Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TUCATINIB Cause Hepatic neoplasm? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hepatic neoplasm have been filed in association with TUCATINIB (TUKYSA). This represents 0.1% of all adverse event reports for TUCATINIB.

7
Reports of Hepatic neoplasm with TUCATINIB
0.1%
of all TUCATINIB reports
1
Deaths
0
Hospitalizations

How Dangerous Is Hepatic neoplasm From TUCATINIB?

Of the 7 reports, 1 (14.3%) resulted in death.

Is Hepatic neoplasm Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TUCATINIB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does TUCATINIB Cause?

Diarrhoea (1,587) Nausea (862) Fatigue (843) Vomiting (483) Death (400) Off label use (392) Malignant neoplasm progression (361) Palmar-plantar erythrodysaesthesia syndrome (355) Product dose omission issue (332) Asthenia (322)

What Other Drugs Cause Hepatic neoplasm?

OCTREOTIDE (300) ADALIMUMAB (98) LANREOTIDE (85) EVEROLIMUS (84) AMLODIPINE (74) ROSUVASTATIN (55) IMATINIB (51) BEVACIZUMAB (49) RIBAVIRIN (49) METFORMIN (47)

Which TUCATINIB Alternatives Have Lower Hepatic neoplasm Risk?

TUCATINIB vs TUCIDINOSTAT TUCATINIB vs TYKERB TUCATINIB vs TYLENOL TUCATINIB vs TYROTHRICIN TUCATINIB vs TYSABRI

Related Pages

TUCATINIB Full Profile All Hepatic neoplasm Reports All Drugs Causing Hepatic neoplasm TUCATINIB Demographics